KBC Group NV Has $17.29 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

KBC Group NV lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 179.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 184,258 shares of the company's stock after purchasing an additional 118,214 shares during the quarter. KBC Group NV's holdings in GE HealthCare Technologies were worth $17,292,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Pathway Financial Advisers LLC purchased a new position in GE HealthCare Technologies during the first quarter worth approximately $25,000. LGT Financial Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 251 shares during the last quarter. Fred Alger Management LLC purchased a new position in shares of GE HealthCare Technologies in the 2nd quarter worth $26,000. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies in the third quarter valued at $26,000. Finally, Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies in the third quarter valued at $26,000. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have commented on GEHC shares. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. UBS Group downgraded shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and dropped their target price for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Redburn Atlantic raised shares of GE HealthCare Technologies to a "strong-buy" rating in a research report on Thursday, August 1st. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 1st. Finally, BTIG Research upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price on the stock in a report on Wednesday, September 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $94.36.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Trading Down 1.4 %

Shares of GEHC stock opened at $81.76 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $66.39 and a 12 month high of $94.55. The company has a market cap of $37.35 billion, a PE ratio of 22.46, a price-to-earnings-growth ratio of 3.02 and a beta of 1.24. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The business's 50 day moving average is $88.70 and its two-hundred day moving average is $83.43.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same period last year, the business posted $0.99 EPS. GE HealthCare Technologies's revenue was up .9% compared to the same quarter last year. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.03 per share. The ex-dividend date was Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.15%. GE HealthCare Technologies's payout ratio is 3.30%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.